Population-Level Trends in Asthma Exacerbations After Introduction of Respiratory Biologics - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Trends in Asthma Exacerbations at the Population Level Following the Adoption of Respiratory Biologics

  • By

  • Yung-Fang Tu

  • David W. Stein

  • Ayobami Akenroye

  • June 24, 2026

Share

  • 1

    Asthma significantly contributes to global morbidity and mortality, especially among patients with severe asthma.

  • 2

    The approval of monoclonal antibodies has provided alternatives to systemic corticosteroids for severe asthma management.

  • 3

    The respiratory biologics boom occurred between 2015 and 2018, with multiple biologics approved for asthma treatment.

  • 4

    This study analyzed population-level asthma exacerbation trends before and after the introduction of respiratory biologics.

  • 5

    Subgroup analyses were conducted to assess treatment effects based on demographic and clinical characteristics.

Original Source(s)

Population-Level Trends in Asthma Exacerbations After Introduction of Respiratory Biologics

  • by Yung-Fang Tu, David W. Stein, Ayobami Akenroye

  • June 24, 2026

Related Content

Language Disparities in the PFT Lab: Implications for PFT Lab Quality Performance

Blomia tropicalis allergens induce lung DNA methylation changes in neuroimmune genes in a mouse model of airway inflammation

Beta-2 Agonists Tied to ASD Risk?

Systematic review of 8 observational studies found limited evidence on associations between prenatal asthma-medication exposure and neurodevelopmental outcomes, with autism spectrum disorder the only outcome suitable for meta-analysis.